Epicardial fat volume is associated with preexisting atrioventricular conduction abnormalities and increased pacemaker implantation rate in patients undergoing transcatheter aortic valve implantation.

Aortic valve stenosis Conduction disorders Epicardial fat tissue

Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
26 Dec 2021
Historique:
received: 14 10 2021
accepted: 19 12 2021
entrez: 26 12 2021
pubmed: 27 12 2021
medline: 27 12 2021
Statut: aheadofprint

Résumé

Epicardial fat tissue (EFT) is a highly metabolically active fat depot surrounding the heart and coronary arteries that is related to early atherosclerosis and adverse cardiac events. We aimed to investigate the relationship between the amount of EFT and preexisting cardiac conduction abnormalities (CCAs) and the need for new postinterventional pacemaker in patients with severe aortic stenosis planned for transcatheter aortic valve implantation (TAVI). A total of 560 consecutive patients (54% female) scheduled for TAVI were included in this retrospective study. EFT volume was measured via a fully automated artificial intelligence software (QFAT) using computed tomography (CT) performed before TAVI. Baseline CCAs [first-degree atrioventricular (AV) block, right bundle branch block (RBBB), and left bundle branch block (LBBB)] were diagnosed according to 12-lead ECG before TAVI. Aortic valve calcification was determined by the Agatston score assessed in the pre-TAVI CT. The median EFT volume was 129.5 ml [IQR 94-170]. Baseline first-degree AV block was present in 17%, RBBB in 10.4%, and LBBB in 10.2% of the overall cohort. In adjusted logistic regression analysis, higher EFT volume was associated with first-degree AV block (OR 1.006 [95% CI 1.002-1.010]; p = 0.006) and the need for new pacemaker implantation after TAVI (OR 1.005 [95% CI 1.0-1.01]; p = 0.035) but not with the presence of RBBB or LBBB. EFT volume did not correlate with the Agatston score of the aortic valve. Greater EFT volume is associated independently with preexisting first-degree AV block and new pacemaker implantation in patients undergoing TAVI. It may play a causative role in degenerative processes and the susceptibility of the AV conduction system.

Identifiants

pubmed: 34954805
doi: 10.1007/s10554-021-02502-x
pii: 10.1007/s10554-021-02502-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2021. The Author(s).

Références

Iacobellis G, Bianco AC (2011) Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 22(11):450–457. https://doi.org/10.1016/j.tem.2011.07.003
doi: 10.1016/j.tem.2011.07.003 pubmed: 21852149 pmcid: 4978122
Villasante Fricke AC, Iacobellis G (2019) Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. Int J Mol Sci. https://doi.org/10.3390/ijms20235989
doi: 10.3390/ijms20235989 pubmed: 31795098 pmcid: 6929015
Rabkin SW (2007) Epicardial fat: properties, function and relationship to obesity. Obes Rev 8(3):253–261. https://doi.org/10.1111/j.1467-789X.2006.00293.x
doi: 10.1111/j.1467-789X.2006.00293.x pubmed: 17444966
Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O’Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460–2466. https://doi.org/10.1161/01.CIR.0000099542.57313.C5
doi: 10.1161/01.CIR.0000099542.57313.C5 pubmed: 14581396
Mancio J, Azevedo D, Saraiva F, Azevedo AI, Pires-Morais G, Leite-Moreira A, Falcao-Pires I, Lunet N, Bettencourt N (2018) Epicardial adipose tissue volume assessed by computed tomography and coronary artery disease: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging 19(5):490–497. https://doi.org/10.1093/ehjci/jex314
doi: 10.1093/ehjci/jex314 pubmed: 29236951
Conceicao G, Martins D, Miranda IM, Leite-Moreira AF, Vitorino R, Falcao-Pires I (2020) Unraveling the role of epicardial adipose tissue in coronary artery disease: partners in crime? Int J Mol Sci. https://doi.org/10.3390/ijms21228866
doi: 10.3390/ijms21228866 pubmed: 33238643 pmcid: 7700147
Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O’Donnell CJ, Fox CS (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 117(5):605–613. https://doi.org/10.1161/CIRCULATIONAHA.107.743062
doi: 10.1161/CIRCULATIONAHA.107.743062 pubmed: 18212276
Coisne A, Ninni S, Ortmans S, Davin L, Kasprzak K, Longere B, Seunes C, Coppin A, Mouton S, Ridon H, Klein C, Noirot-Cosson B, Staels B, Lancellotti P, Montaigne D, Pontana F (2019) Epicardial fat amount is associated with the magnitude of left ventricular remodeling in aortic stenosis. Int J Cardiovasc Imaging 35(2):267–273. https://doi.org/10.1007/s10554-018-1477-z
doi: 10.1007/s10554-018-1477-z pubmed: 30334229
Conte M, Petraglia L, Campana P, Gerundo G, Caruso A, Grimaldi MG, Russo V, Attena E, Leosco D, Parisi V (2020) The role of inflammation and metabolic risk factors in the pathogenesis of calcific aortic valve stenosis. Aging Clin Exp Res. https://doi.org/10.1007/s40520-020-01681-2
doi: 10.1007/s40520-020-01681-2 pubmed: 32978752 pmcid: 8249252
Cho KI, Sakuma I, Sohn IS, Jo SH, Koh KK (2018) Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease. Atherosclerosis 277:60–65. https://doi.org/10.1016/j.atherosclerosis.2018.08.029
doi: 10.1016/j.atherosclerosis.2018.08.029 pubmed: 30173080
Cheng SKM, Larson MG, McCabe EL, Newton-Cheh C, Levy D, Benjamin EJ, Vasan RS, Wang TJ (2009) Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA 301(24):2571–2577
doi: 10.1001/jama.2009.888
Oldroyd SH, Quintanilla Rodriguez B, Makaryus AN (2021) First degree heart block. StatPearls Publishing, Treasure Island
Harkness WT, Hicks M (2021) Right bundle branch block. StatPearls, Treasure Island
Tan NY, Witt CM, Oh JK, Cha Y-M (2020) Left bundle branch block. Circ Arrhythm Electrophysiol. https://doi.org/10.1161/circep.119.008239
doi: 10.1161/circep.119.008239 pubmed: 32186936
Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology, European Association for Cardio-Thoracic Surgeons, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451–2496. https://doi.org/10.1093/eurheartj/ehs109
Kim WK, Renker M, Rolf A, Fischer-Rasokat U, Wiedemeyer J, Doss M, Mollmann H, Walther T, Nef H, Hamm CW, Liebetrau C (2019) Annular versus supra-annular sizing for TAVI in bicuspid aortic valve stenosis. EuroIntervention 15(3):e231–e238. https://doi.org/10.4244/EIJ-D-19-00236
doi: 10.4244/EIJ-D-19-00236 pubmed: 31147305
Commandeur F, Goeller M, Razipour A, Cadet S, Hell MM, Kwiecinski J, Chen X, Chang HJ, Marwan M, Achenbach S, Berman DS, Slomka PJ, Tamarappoo BK, Dey D (2019) Fully automated CT quantification of epicardial adipose tissue by deep learning: a multicenter study. Radiol Artif Intell 1(6):e190045. https://doi.org/10.1148/ryai.2019190045
doi: 10.1148/ryai.2019190045 pubmed: 32090206 pmcid: 6884062
Dey D, Wong ND, Tamarappoo B, Nakazato R, Gransar H, Cheng VY, Ramesh A, Kakadiaris I, Germano G, Slomka PJ, Berman DS (2010) Computer-aided non-contrast CT-based quantification of pericardial and thoracic fat and their associations with coronary calcium and metabolic syndrome. Atherosclerosis 209(1):136–141. https://doi.org/10.1016/j.atherosclerosis.2009.08.032
doi: 10.1016/j.atherosclerosis.2009.08.032 pubmed: 19748623
Al Chekakie MO, Welles CC, Metoyer R, Ibrahim A, Shapira AR, Cytron J, Santucci P, Wilber DJ, Akar JG (2010) Pericardial fat is independently associated with human atrial fibrillation. J Am Coll Cardiol 56(10):784–788. https://doi.org/10.1016/j.jacc.2010.03.071
doi: 10.1016/j.jacc.2010.03.071 pubmed: 20797492
Batal O, Schoenhagen P, Shao M, Ayyad AE, Van Wagoner DR, Halliburton SS, Tchou PJ, Chung MK (2010) Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol 3(3):230–236. https://doi.org/10.1161/CIRCEP.110.957241
doi: 10.1161/CIRCEP.110.957241 pubmed: 20504944 pmcid: 2974566
Mirolo A, Viart G, Savoure A, Godin B, Raitiere O, Eltchaninoff H, Anselme F (2019) Epicardial fat thickness predicts atrial fibrillation recurrence after a first pulmonary vein isolation procedure using a second-generation cryoballoon. Arch Cardiovasc Dis 112(5):314–322. https://doi.org/10.1016/j.acvd.2018.11.011
doi: 10.1016/j.acvd.2018.11.011 pubmed: 30670363
Hung WC, Tang WH, Wang CP, Lu LF, Chung FM, Lu YC, Hsu CC, Tsai IT, Jhuo SJ, Lai WT, Lee YJ, Ya TH (2015) Increased epicardial adipose tissue volume is associated with PR interval prolongation. Clin Investig Med 38(2):E45-52. https://doi.org/10.25011/cim.v38i1.22575
doi: 10.25011/cim.v38i1.22575
Jhuo SJ, Hsieh TJ, Tang WH, Tsai WC, Lee KT, Yen HW, Lai WT (2018) The association of the amounts of epicardial fat, P wave duration, and PR interval in electrocardiogram. J Electrocardiol 51(4):645–651. https://doi.org/10.1016/j.jelectrocard.2018.04.009
doi: 10.1016/j.jelectrocard.2018.04.009 pubmed: 29997005
Siontis GC, Juni P, Pilgrim T, Stortecky S, Bullesfeld L, Meier B, Wenaweser P, Windecker S (2014) Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 64(2):129–140. https://doi.org/10.1016/j.jacc.2014.04.033
doi: 10.1016/j.jacc.2014.04.033 pubmed: 25011716
Mangieri A, Montalto C, Pagnesi M, Lanzillo G, Demir O, Testa L, Colombo A, Latib A (2018) TAVI and post procedural cardiac conduction abnormalities. Front Cardiovasc Med 5:85. https://doi.org/10.3389/fcvm.2018.00085
doi: 10.3389/fcvm.2018.00085 pubmed: 30018969 pmcid: 6038729
Rajani R, Shmilovich H, Nakazato R, Nakanishi R, Otaki Y, Cheng VY, Hayes SW, Thomson LE, Friedman JD, Slomka PJ, Min JK, Berman DS, Dey D (2013) Relationship of epicardial fat volume to coronary plaque, severe coronary stenosis, and high-risk coronary plaque features assessed by coronary CT angiography. J Cardiovasc Comput Tomogr 7(2):125–132. https://doi.org/10.1016/j.jcct.2013.02.003
doi: 10.1016/j.jcct.2013.02.003 pubmed: 23622507 pmcid: 3729230
Yu W, Liu B, Zhang F, Wang J, Shao X, Yang X, Shi Y, Wang B, Xu Y, Wang Y (2021) Association of epicardial fat volume with increased risk of obstructive coronary artery disease in Chinese patients with suspected coronary artery disease. J Am Heart Assoc 10(6):e018080. https://doi.org/10.1161/JAHA.120.018080
doi: 10.1161/JAHA.120.018080 pubmed: 33660521 pmcid: 8174213
Tanaka K, Sata M (2018) Roles of perivascular adipose tissue in the pathogenesis of atherosclerosis. Front Physiol 9:3. https://doi.org/10.3389/fphys.2018.00003
doi: 10.3389/fphys.2018.00003 pubmed: 29487532 pmcid: 5816816
Parisi V, Rengo G, Pagano G, D’Esposito V, Passaretti F, Caruso A, Grimaldi MG, Lonobile T, Baldascino F, De Bellis A, Formisano P, Ferrara N, Leosco D (2015) Epicardial adipose tissue has an increased thickness and is a source of inflammatory mediators in patients with calcific aortic stenosis. Int J Cardiol 186:167–169. https://doi.org/10.1016/j.ijcard.2015.03.201
doi: 10.1016/j.ijcard.2015.03.201 pubmed: 25819894
Nabati M, Favaedi M, Kheirgoo M, Yazdani J, Dabirian M (2018) Correlation between epicardial fat thickness and aortic valve sclerosis. Asian Cardiovasc Thorac Ann 26(3):188–195. https://doi.org/10.1177/0218492318760692
doi: 10.1177/0218492318760692 pubmed: 29444599
Mahabadi AAKH, Dykun I, Balcer B, Kahlert P, Rassaf T (2017) Epicardial adipose tissue thickness independently predicts severe aortic valve stenosis. J Heart Valve Dis 26(3):262–267
pubmed: 29092109

Auteurs

Maren Weferling (M)

Department of Cardiology, Kerckhoff Heart and Thorax Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany. m.weferling@kerckhoff-klinik.de.
German Centre for Cardiovascular Research (DZHK), Partner Site RheinMain, Frankfurt, Germany. m.weferling@kerckhoff-klinik.de.

Andreas Rolf (A)

Department of Cardiology, Kerckhoff Heart and Thorax Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany.

Ulrich Fischer-Rasokat (U)

Department of Cardiology, Kerckhoff Heart and Thorax Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany.

Christoph Liebetrau (C)

Cardioangiological Center Bethanien (CCB), Department of Cardiology, Agaplesion Bethanien Hospital, Frankfurt, Germany.

Matthias Renker (M)

Department of Cardiology, Kerckhoff Heart and Thorax Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany.
Department of Cardiac Surgery, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.

Yeoung-Hoon Choi (YH)

Department of Cardiac Surgery, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.

Christian W Hamm (CW)

Department of Cardiology, Kerckhoff Heart and Thorax Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site RheinMain, Frankfurt, Germany.
Department of Cardiology, University Hospital of Giessen, Giessen, Germany.

Damini Dey (D)

Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Taper A238, Los Angeles, CA, 90048, USA.

Won-Keun Kim (WK)

Department of Cardiology, Kerckhoff Heart and Thorax Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site RheinMain, Frankfurt, Germany.
Department of Cardiac Surgery, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.

Classifications MeSH